Pricing Log in Create free account
Sunday 18 October 2026 Export DYNTQ’s income statement to Excel — free account

Dynatronics Corporation

DYNTQ Healthcare Medical Devices

Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024. In the quarter to September 2025, revenue fell 7.61%, EPS grew 66.7% and free cash flow fell 193.0%, each against the same quarter a year earlier.

0.00 0.00 NaN
Market cap
$1.2M
P/E
0.0×
Fwd P/E
−1.5×
Dividend yield
—
F-score
3/9
Altman Z
−2.33
Beneish M
−6.52
Dividend safety
n/a
Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 82.28%

Capital & Financial Ratios $m

Market Cap 1.18
Revenue 26.81
Net Income (10.74)
Free Cash Flow 0.08
Net Debt 2.82
Current Ratio 1.07
Debt/Equity 1.19
P/E ratio 0.00
Fwd P/E (1.51) (negative: loss-making)
P/S ratio 0.00
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 37.00% (at or above 15%: strong)
Next Y EPS Growth —
Next Y revenue growth 13.73% (at or above 10%: strong)
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.1×, against a ten-year median of 0.3×; over the ten years it ranged from 0.1× in 2026 to 0.5× in 2018.
EV/Sales against its own 10 years 0.37%
10-year low 10-year high
EV/FCF against its own 10 years 58.08%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'25
Cash 1 1 0 1
Receivables 4 4 3 3
Inventory 7 6 5 5
Other — — — —
12 11 9 9
2023 2024 2025 Q'25
Payables 5 3 3 3
ST’ Debt 1 2 2 3
Other 0 0 0 0
8 8 8 8

Compound Annual Growth %

10y 5y 3y
Sales (0.61%) (12.50%) (14.83%)
Cash Flow 0.00% (37.25%) 0.00%
Earnings 0.00% 0.00% 0.00%
Book Value (7.75%) (30.35%) (46.83%)

Revenue $m

Sep Dec Mar Jun Year
’26 7 — — — —
’25 8 7 6 6 27
’24 9 8 8 7 33
’23 12 11 9 8 41
’22 12 11 10 11 44
’21 12 12 11 12 48
’20 16 15 14 8 53
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Sep Dec Mar Jun Year
’26 0 — — — —
’25 0 0 0 0 0
’24 (2) 0 0 0 (2)
’23 0 0 0 0 0
’22 (1) (2) (1) (2) (5)
’21 1 2 (2) 0 0
’20 2 1 0 1 3
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Sep Dec Mar Jun Year
’26 0 — — — —
’25 0 0 0 0 0
’24 (2) 0 0 0 (2)
’23 0 0 0 0 0
’22 (1) (2) (1) (2) (5)
’21 1 1 (2) 2 2
’20 2 1 0 0 3
Fiscal quarters ending in the months shown.

EPS $

Sep Dec Mar Jun Year
’26 (0.03) — — — —
’25 (0.09) (0.13) (0.13) (1.06) (1.43)
’24 (0.12) (0.27) (0.17) (0.35) (1.00)
’23 (0.20) (0.27) (0.36) (0.63) (1.46)
’22 0.10 (0.45) (0.45) (0.50) (1.30)
’21 (0.20) (0.30) 0.00 0.80 0.40
’20 (0.05) (0.25) (0.65) (1.11) (2.10)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to June

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 11.44 10.50 11.85 3.15 2.61 4.00 1.50 0.47 0.08 0.04

Analyst estimates 2026–2028

Powerpack
High 16.05 18.75 18.00 14.20 18.50 12.80 5.35 2.73 0.73 0.19
People
People Employees 153 233 336 284 195 175 197 156 112 88
Revenue/emp, $m 0.20 0.15 0.19 0.22 0.27 0.27 0.23 0.26 0.29 0.31
Income, $m
Income, $m Revenue 30 36 64 63 53 48 44 41 33 27
Gross margin, % 34.05 32.18 31.70 30.65 28.27 26.96 24.07 24.99 23.47 21.94
EBT (2) (2) (2) (1) (3) 2 (4) (5) (3) (11)
EBT margin, % (6.47) (5.22) (2.60) (1.46) (6.43) 4.17 (9.01) (12.25) (8.29) (39.75)
Net income (2) (2) (2) (1) (3) 2 (4) (5) (3) (11)
Depreciation 1 1 1 2 2 1 1 1 1 8
Per share, $
Per share, $ Revenue 56.19 56.72 48.64 37.94 26.02 15.46 12.42 10.49 9.51 3.37
Earnings (4.20) (6.80) (2.65) (1.05) (2.10) 0.40 (1.30) (1.46) (1.00) (1.43)
Cash flow (0.99) (2.42) 0.58 0.20 1.51 0.12 (1.37) 0.10 (0.47) 0.04
Capex (0.36) (0.14) (0.17) (0.14) (0.14) 0.50 (0.09) (0.05) (0.07) 0.00
Free cash flow (1.35) (2.56) 0.40 0.06 1.36 0.62 (1.46) 0.05 (0.54) 0.03
Book value 10.33 19.55 16.14 12.59 9.69 8.25 6.08 4.35 4.14 0.40
Shares, m 1 1 1 2 2 3 4 4 3 8
Valuation, ×
Valuation, × P/E 0.00 0.00 0.00 0.00 0.00 20.00 0.00 0.00 0.00 0.00
P/S 0.26 0.25 0.30 0.22 0.17 0.39 0.25 0.07 0.02 0.02
P/B 4.28 2.31 2.01 1.54 0.81 1.06 0.79 0.33 0.12 0.00
EV/Sales 0.36 0.40 0.43 0.38 0.26 0.31 0.27 0.13 0.12 0.12
EV/FCF (15.11) (8.95) 51.91 231.51 4.98 7.62 (2.33) 29.56 (2.03) 12.61
Cash, $m
Cash, $m Operating cash flow (1) (2) 1 0 3 0 (5) 0 (2) 0
Capex 0 0 0 0 0 2 0 0 0 0
Free cash flow (1) (2) 1 0 3 2 (5) 0 (2) 0
Balance, $m
Balance, $m Working capital 6 6 7 6 8 12 9 4 3 1
Total debt 4 6 10 10 7 2 2 3 4 3
Net debt 3 6 8 10 5 (4) 1 3 3 3
Shareholders’ equity 6 12 21 21 20 26 22 17 14 3
Returns, %
Returns, % ROA (13.21) (20.77) (10.27) (4.20) (11.18) 3.15 (12.68) (17.30) (12.24) (56.08)
ROIC (12.33) (5.83) (2.66) (1.64) (7.54) (10.91) (12.96) (15.63) (8.27) (25.59)
ROE (83.35) (150.56) (51.61) (18.21) (42.66) 8.44 (30.25) (50.14) (45.55) (1,588.36)
Negative figures in brackets.

All 10 years →

Fiscal years to Jun 2025 · latest quarter Sep 2025

Charts ten years each

Dynatronics Corporation vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NUVOQ Holdco Nuvo Group D.G Ltd. $2.1M — (loss-making) — — n/m −1.05% (below 0%: shrinking) 0.00% 0.00% Compare
VJET Flyte Aviation, Inc. $2.1M — (loss-making) — (loss-making) +380.66% (above 0%: growing) n/m −26.70% (below 0%: shrinking) 9.62% (388.13%) Compare
NUWE Nuwellis, Inc. $2.0M — (loss-making) — (loss-making) +14.14% (above 0%: growing) n/m −51.55% (below 0%: shrinking) 76.08% (160.94%) Compare
AFIB Acutus Medical, Inc. $1.7M — (loss-making) — (loss-making) +204.18% (above 0%: growing) n/m +76.40% (above 0%: growing) 14.20% (3.81%) Compare
DHAI DIH Holding US, Inc. $1.6M — (loss-making) — −30.67% (below 0%: shrinking) n/m −167.90% (below 0%: shrinking) 50.33% (33.62%) Compare
DYNTQ Dynatronics Corporation $1.2M — (loss-making) — (loss-making) −7.61% (below 0%: shrinking) n/m −193.04% (below 0%: shrinking) 24.65% (1.26%)
THMO ThermoGenesis Holdings, Inc. $1.1M — (loss-making) 5.5× +6.42% (above 0%: growing) n/m +62.12% (above 0%: growing) 43.92% (20.35%) Compare
SSKN Strata Skin Sciences, Inc. $1.0M — (loss-making) — (loss-making) −2.97% (below 0%: shrinking) n/m −376.88% (below 0%: shrinking) 61.82% 7.66% Compare
FEED ENvue Medical, Inc. $950.0K — (loss-making) — (loss-making) −51.62% (below 0%: shrinking) n/m +19.75% (above 0%: growing) (111.30%) (2,290.38%) Compare
Median of peers $1.6M — — +6.42% — −13.87% 29.06% (26.98%)

All 149 Medical Devices stocks →

Dynatronics Corporation (DYNTQ) key facts

  • Concern: Dynatronics Corporation’s revenue for fiscal 2025 (year ended June 2025) was $27.4 million, down 15.8% from fiscal 2024.
  • Dynatronics Corporation (DYNTQ) is a Medical Devices company in the Healthcare sector.
  • Return on equity was −1,588.4% and debt-to-equity 1.19.
  • Its Piotroski F-score is 3 out of 9 and its Altman Z-score is −2.33 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Dynatronics Corporation (DYNTQ) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/DYNTQ · Data as of Sep 30, 2025 · For information only; not investment advice. · © 2026 stockrow.com